ICAS Screen Based on RIC

Recruiting Observational Study
Intracranial Atherosclerosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,100 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Intracranial atherosclerosis stenosis (ICAS) is a leading cause of ischemic stroke worldwide and increase the global burden of stroke, especially in the Asian population. Compared with the other stroke subtypes, patients with ICAS had more severe stroke, stayed longer in the hospital and higher risk of recurrent ischemic events. Thus, early screening and effective intervention for intracranial ath…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. The age is above 18 years old; 2. Complete head and neck DSA, CTA, MRA or HR-MRI examination within 2 weeks; 3. He/She can cooperate with follow-up fundus examination with free movement; 4. Signed informed consent. Exclusion Criteria: 1. Poor quality of fundus images; 2. Wi…
Contacts

Gao

86+01083199439

gychina163@163.com

CONTACT